Actelion Pharmaceuticals Ltd

Type: Company
Name: Actelion Pharmaceuticals Ltd (Actelion Ltd)
Nationality: Switzerland
Web Address: http://www.actelion.com/
Fact Sheet: Fact Sheet for Actelion Ltd
First reported Oct 17 2014 - Updated Oct 17 2014 - 1 reports

Regeneron tops best science employer poll again

Regeneron has once again come top of Science magazine’s top 20 employers survey, followed by Novo Nordisk and Roche’s Genentech unit.The poll is based on 5,394 responses from readers of Science and employees in the biotechnology and pharmaceutical industry, ... [Published Pharma Times - Oct 17 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Swiss Stocks Tumble, Led By Nestle And Big Banks

Swiss stocks fell sharply on Thursday, extending steep recent losses as big banks were pressured by concerns about the euro area financial system.The Swiss Market Index dropped 1.07 percent to 8,057.54. At one point the SMI fell below 8,000 for the first ... [Published RTTNews.com - Oct 16 2014]
Entities: Nestlé SA, Stocks, Bank
First reported Oct 15 2014 - Updated Oct 16 2014 - 1 reports

Swiss Stocks Capitulate To Global Sell-off

Swiss stocks were battered Wednesday, falling to their lowest since August amid a global market meltdown sparked by economic and geopolitical jitters.Led by slumping banks, the Swiss Market Index tumbled 2.3 percent to 8,144,88 points, after reaching ... [Published RTTNews.com - Oct 15 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

A Look At Arena's Other Drug

Summary Arena Pharmaceuticals is developing APD811 for treatment of pulmonary arterial hypertension or PAH, a rare disease. The drug has been granted an Orphan drug status by the FDA and the company is looking to advance it to a Phase II trial. PAH ... [Published Seeking Alpha - Oct 03 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

Swiss Stocks Rise But UBS Slides On Fears Of Massive French Fine

Swiss stocks inched higher Friday, as most of Europe cheered an upbeat U.S. jobs report for September.The Labor Department said that the U.S. unemployment rate unexpectedly fell to 5.9 percent, its lowest level in over six years.The Swiss Market Index ... [Published RTTNews.com - Oct 03 2014]
First reported Sep 23 2014 - Updated Sep 24 2014 - 1 reports

AstraZeneca, Shire dive as U.S. tax move punctures deal hopes

LONDON - Shares in drugmakers AstraZeneca and Shire fell sharply on Tuesday after the U.S. Treasury took steps to curb "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad.The move could jeopardize an agreed deal ... [Published Today Online - Sep 23 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 3 reports

Inversion deal crackdown hits stocks

A handful of companies that investors once viewed as ripe for takeover by US rivals isn't looking so attractive, after the White House unveiled a sweeping effort at cracking down on the tax benefits of cross-Atlantic mergers.The Obama administration moved ... [Published Business Spectator - Sep 23 2014]
Entities: AbbVie Inc, Inversion, Taxes
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Swiss Stocks Fall Further From 6-Year Highs

Swiss stocks edged down for a second day in a row Tuesday, although losses were more pronounced in other major European markets.The Swiss Market Index slipped 0.61 percent to 8,763.80 at last check, moving further from 6-year highs seen earlier this month. ... [Published RTTNews.com - Sep 23 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Tax-deal crackdown's victims, say analysts? Mylan and Abbott, not Pfizer and AZ

Pfizer and AstraZeneca, AbbVie and Shire, Hospira and Danone. Those are a few of the merger pairs--actual or potential--that stand to lose from U.S. Treasury Secretary Jack Lew's new tax-inversion-fighting rules. Just take a look at AstraZeneca and Shire's ... [Published FiercePharma - Sep 23 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 2 reports

UPDATE 1-AstraZeneca, Shire fall as U.S. tax move punctures deal hopes

* U.S. moves against tax-avoidance 'inversion' deals* May deter Pfizer from returning to bid for AstraZeneca* Seen as threat to Shire's agreed sale to AbbVie* Smith & Nephew, Actelion also down on fading bid hopes(Adds analyst comments, details)LONDON, ... [Published CNBC - Sep 23 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Portfolio Update

Regulatory Story Company TIDM IBT Headline Released 10:14 22-Sep-2014 Number 2392S10 RNS Number : 2392S 22 September 2014  INTERNATIONAL BIOTECHNOLOGY TRUST PLC Portfolio Update as at 31 August 2014 Net Assets £215m Net Assets per share 396p Share price ... [Published London Stock Exchange - Sep 22 2014]
First reported Aug 05 2014 - Updated Aug 06 2014 - 2 reports

Actelion becomes latest recruit to join PatientsLikeMe

PatientsLikeMe and Actelion have come together in order to help create a new patient -reported outcomes tool for the rare form of blood cancer called MF-CTCL.The collaboration will use PatientsLikeMe’s open research exchange (ORE), an online hub for ... [Published BioPortfolio - Aug 06 2014]

Quotes

...products marketed as XIAFLEX ® (collagenase clostridium histolyticum or CCH) in the U S and XIAPEX ® in the EU, announces that a paper titled, "Stiffness of Human Uterine Fibroids is Reduced After Treatment with Purified Clostridial Collagenase due to Collagen Degradation" was presented at the Mechanotransduction in the Reproductive Tract conference hosted by the Campion Fund of the Phyllis and Mark Leppert Foundation for...
"The potential for a 20 Oct. modification of the deal or indeed a full withdrawal is likely to have a significant knock-on for sentiment towards corporate activity, given how this year's strong flow of M&A helped markets towards recent highs. Beware the fallout" Mike van Dulken, head of research at Accendo Markets, said in a note
"Our take-home to clinicians is to avoid higher-risk agents in FES patients, promote a healthy lifestyle, do the monitoring, and integrate physical and mental health care."
"At the moment there are 3,000 to 3,500 people in England that have been diagnosed with PAH, but there could be as many as 2,000 to 3,000 more that have not been diagnosed" he explains

More Content

All (87) | News (56) | Reports (0) | Blogs (26) | Audio/Video (0) | Fact Sheets (2) | Press Releases (1)
sort by: Date | Relevance
Regeneron tops best science employer poll again [Published Pharma Times - Oct 17 2014]
Swiss Stocks Tumble, Led By Nestle And Big Banks [Published RTTNews.com - Oct 16 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published Fat Pitch Financials - Oct 16 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published Stock Nod - Oct 16 2014]
Biotech bucks macro uncertainties - strong quar... [Published Nasdaq - Oct 16 2014]
Swiss Stocks Capitulate To Global Sell-off [Published RTTNews.com - Oct 15 2014]
Is the AbbVie-Shire deal dead? Stock market thi... [Published Morningstar.com - Oct 15 2014]
Rapid Rise in Cardiometabolic Risk in Early Sch... [Published Theheart.org - Oct 14 2014]
Rigontec raises $11.95 mln [Published PE Hub Blog - Oct 14 2014]
A new ERA for pulmonary arterial hypertension p... [Published Pharmaceutical Technology - Oct 13 2014]
Association Between Vancomycin Minimum Inhibito... [Published Journal of the American Medical Association - Oct 09 2014]
Global Lysosomal Storage Diseases market foreca... [Published Live-PR.com - Oct 09 2014]
BioSpecifics Technologies Corp. Announces Sudde... [Published Town Hall - Oct 08 2014]
New Haven Pharmaceuticals Expands Management Te... [Published Wall Street Select - Oct 08 2014]
New Haven Pharmaceuticals Expands Management Te... [Published Yahoo! Finance - Oct 08 2014]
Molecular Diagnostics Partnering Terms and Agre... [Published Individual.com - Oct 08 2014]
A Look At Arena's Other Drug [Published Seeking Alpha - Oct 03 2014]
Swiss Stocks Rise But UBS Slides On Fears Of Ma... [Published RTTNews.com - Oct 03 2014]
Crackdown on Corporate Inversion Applies Pressu... [Published Zolmax News - Sep 23 2014]
Inversion deal crackdown hits stocks [Published Business Spectator - Sep 23 2014]
Shares Of 'inversion' Candidates Slide On U.S. ... [Published Clusterstock - Sep 23 2014]
Swiss Stocks Fall Further From 6-Year Highs [Published RTTNews.com - Sep 23 2014]
Tax-deal crackdown's victims, say analysts? Myl... [Published FiercePharma - Sep 23 2014]
Tax inversion target companies hit by U.S. crac... [Published Fortune - Sep 23 2014]
AstraZeneca, Shire dive as U.S. tax move punctu... [Published Today Online - Sep 23 2014]
AstraZeneca, Shire Dive As U.S. Tax Move Punctu... [Published Clusterstock - Sep 23 2014]
Drug company shares pummeled by US tax moves [Published CNBC - Sep 23 2014]
UPDATE 1-AstraZeneca, Shire fall as U.S. tax mo... [Published CNBC - Sep 23 2014]
BUZZ-Shire, AstraZeneca bearing the brunt as ne... [Published London South East - Sep 23 2014]
Pulmonary Disease Under-recognized in HIV [Published American Journal of Public Health - Sep 22 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Rigontec raises $11.95 mln [Published PE Hub Blog - Oct 14 2014]
Rigontec GmbH said Tuesday it raised €9.45 million (US$11.95 million) in a first close of a Series A round co-led by Wellington Partners and Boehringer Ingelheim Venture Fund . Other investors include NRW Bank and High-Tech Gründerfonds . Rigontec, ...
Shares Of 'inversion' Candidates Slide On U.S. ... [Published Clusterstock - Sep 23 2014]
By Ben Hirschler and Dan Burns LONDON/NEW YORK (Reuters) - The U.S. Treasury's move to curb deals that allow U.S. companies to escape high taxes at home wiped a combined $12.3 billion off the shares of nearly a dozen companies on both sides of the ...
AstraZeneca, Shire Dive As U.S. Tax Move Punctu... [Published Clusterstock - Sep 23 2014]
By Ben Hirschler LONDON (Reuters) - Shares in drugmakers AstraZeneca and Shire fell sharply on Tuesday after the U.S. Treasury took steps to curb "inversion" deals that allow companies to escape high U.S. taxes by reincorporating abroad. The move ...
Research and Markets: Global Lysosomal Storage ... [Published Business Wire Health News - Aug 21 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5f7fvn/global_lysosomal) has announced the addition of the "Global Lysosomal Storage Diseases Market 2014-2018" report to their offering. The Global Lysosomal Storage ...
Global Lysosomal Storage Diseases Market 2014-2... [Published PR Newswire: General Business - Aug 18 2014]
DUBLIN, Aug. 18, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Lysosomal Storage Diseases Market 2014-2018" report to their offering. The term lysosomal storage diseases refers to a group of rare inherited disorders ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
PatientsLikeMe and Actelion to Develop New Pati... [Published PatientsLikeMe Press Release - Aug 05 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.